Advertisement
Research Article

A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison between Rotarix and RotaTeq Vaccines

  • Albert Jan van Hoek,

    Affiliation: Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, London, United Kingdom

    X
  • Mwanajuma Ngama mail,

    MNgama@kemri-wellcome.org

    Affiliation: Kenya Medical Research Institute, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya

    X
  • Amina Ismail,

    Affiliation: Division of Disease Surveillance and Response, Ministry of Public Health and Sanitation, Nairobi, Kenya

    X
  • Jane Chuma,

    Affiliation: Kenya Medical Research Institute, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya

    X
  • Samuel Cheburet,

    Affiliation: Health Information System, Ministry of Health, Nairobi, Kenya

    X
  • David Mutonga,

    Affiliation: Division of Disease Surveillance and Response, Ministry of Public Health and Sanitation, Nairobi, Kenya

    X
  • Tatu Kamau,

    Affiliation: Division of Vaccines & Immunization, Ministry of Public Health and Sanitation, Nairobi, Kenya

    X
  • D. James Nokes

    Affiliations: Kenya Medical Research Institute, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya, School of Life Sciences, University of Warwick, Coventry, United Kingdom

    X
  • Published: October 24, 2012
  • DOI: 10.1371/journal.pone.0047511

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Correction: A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison between Rotarix and RotaTeq Vaccines

Albert Jan van Hoek, Mwanajuma Ngama, Amina Ismail, Jane Chuma, Samuel Cheburet, David Mutonga, Tatu Kamau, D. James Nokes
Correction | published 21 Nov 2012 | PLOS ONE
doi:10.1371/annotation/6b9d910e-4c85-41ca-ae56-b5996e81820a